Financials
Income statement
Fiscal date | Mar 2025 | Jun 2024 | Mar 2024 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 20.3B | 17.1B | 17.9B | 18.4B |
Cost of revenue | 11.1B | 9.2B | 10.2B | 11.3B |
Gross profit | 9.2B | 7.9B | 7.7B | 7.0B |
Operating expense | ||||
Research & development | 1.0B | 1.2B | 812.1M | 3.0B |
Selling general and admin | 1.4B | 1.4B | 1.6B | 1.3B |
Other operating expenses | 28.4M | 268.4M | -21.1M | — |
Operating income | 4.3B | 2.7B | 2.9B | 1.0B |
Non operating interest income | ||||
Income | 384.8M | 355.7M | 310.7M | 202.0M |
Expense | 6.2M | 4.3M | 3.1M | 53.4M |
Other income expense | — | — | — | — |
Pretax income | 4.1B | 3.1B | 4.4B | 1.1B |
Tax provision | 469.1M | 406.0M | 597.9M | 233.8M |
Net income | 3.6B | 2.7B | 3.8B | 865.2M |
Basic EPS | 481 | 363 | 509 | 115 |
Diluted EPS | 481 | 363 | 509 | 115 |
Basic average shares | 7.6M | 7.5M | 7.5M | 7.5M |
Diluted average shares | 7.6M | 7.5M | 7.5M | 7.5M |
EBITDA | 5.5B | 4.4B | 4.6B | 1.4B |
Net income from continuing op. | 3.6B | 2.7B | 3.8B | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |